Cargando…
The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
Cardio-metabolic diseases (CMD) are a spectrum of diseases (e.g., type 2 diabetes, atherosclerosis, non-alcohol fatty liver disease (NAFLD), and metabolic syndrome) that are among the leading causes of morbidity and mortality worldwide. It has long been known that bile acids (BA), which are endogeno...
Autores principales: | Callender, Cengiz, Attaye, Ilias, Nieuwdorp, Max |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778259/ https://www.ncbi.nlm.nih.gov/pubmed/35050187 http://dx.doi.org/10.3390/metabo12010065 |
Ejemplares similares
-
Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions
por: Ryan, Paul M., et al.
Publicado: (2017) -
The Role of the Gut Microbiota on the Beneficial Effects of Ketogenic Diets
por: Attaye, Ilias, et al.
Publicado: (2021) -
The Black Box Orchestra of Gut Bacteria and Bile Acids: Who Is the Conductor?
por: Majait, Soumia, et al.
Publicado: (2023) -
Interactions between Tryptophan Metabolism, the Gut Microbiome and the Immune System as Potential Drivers of Non-Alcoholic Fatty Liver Disease (NAFLD) and Metabolic Diseases
por: Teunis, Charlotte, et al.
Publicado: (2022) -
Rethinking the bile acid/gut microbiome axis in cancer
por: Phelan, John P., et al.
Publicado: (2017)